High-content phenotypic screenings to identify inhibitors of Candida albicans biofilm formation and filamentation

CG Pierce, SP Saville, JL Lopez-Ribot - Pathogens and disease, 2014 - academic.oup.com
Candida species represent the main cause of opportunistic fungal infections worldwide, and
Candida albicans remains the most common etiological agent of candidiasis, now the third …

High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors

SA Siles, A Srinivasan, CG Pierce… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Candida albicans is the most common etiologic agent of systemic fungal infections with
unacceptably high mortality rates. The existing arsenal of antifungal drugs is very limited and …

A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance

CG Pierce, AK Chaturvedi, AL Lazzell… - npj Biofilms and …, 2015 - nature.com
Methods: To address the pressing need for new antifungals, we have performed a high-
content screen of 20,000 small molecules in a chemical library (NOVACore) to identify …

Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation

JA Romo, CG Pierce, AK Chaturvedi, AL Lazzell… - MBio, 2017 - Am Soc Microbiol
Candida albicans remains the main etiologic agent of candidiasis, the most common fungal
infection and now the third most frequent infection in US hospitals. The scarcity of antifungal …

A Screen for Small Molecules to Target Candida albicans Biofilms

MB Lohse, CL Ennis, N Hartooni, AD Johnson… - Journal of Fungi, 2020 - mdpi.com
The human fungal pathogen Candida albicans can form biofilms on biotic and abiotic
surfaces, which are inherently resistant to antifungal drugs. We screened the Chembridge …

Screening the Pathogen Box for identification of Candida albicans biofilm inhibitors

T Vila, JL Lopez-Ribot - Antimicrobial Agents and Chemotherapy, 2017 - Am Soc Microbiol
Candida albicans remains the main causative agent of candidiasis, one of the most frequent
nosocomial infections, with unacceptably high mortality rates. Biofilm formation is a major …

Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs

CG Pierce, JL Lopez-Ribot - Expert opinion on drug discovery, 2013 - Taylor & Francis
Introduction: Targeting pathogenetic mechanisms, rather than essential processes,
represents a very attractive alternative for the development of new antibiotics. This may be …

Transcriptomic and Genomic Approaches for Unravelling Candida albicans Biofilm Formation and Drug Resistance—An Update

PP Chong, VK Chin, WF Wong, P Madhavan, VC Yong… - Genes, 2018 - mdpi.com
Candida albicans is an opportunistic fungal pathogen, which causes a plethora of
superficial, as well as invasive, infections in humans. The ability of this fungus in switching …

In Vitro Characterization of a Biaryl Amide Anti-virulence Compound Targeting Candida albicans Filamentation and Biofilm Formation

JA Romo, CG Pierce, M Esqueda, CY Hung… - Frontiers in cellular …, 2018 - frontiersin.org
We have previously identified a small molecule compound, N-[3-(allyloxy)-phenyl]-4-
methoxybenzamide (9029936), that exerts potent inhibitory activity against filamentation and …

Chemical inhibitors of Candida albicans hyphal morphogenesis target endocytosis

H Bar-Yosef, N Vivanco Gonzalez, S Ben-Aroya… - Scientific reports, 2017 - nature.com
Candida albicans is an opportunistic pathogen, typically found as a benign commensal
yeast living on skin and mucosa, but poised to invade injured tissue to cause local …